Emcure Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: EMCURE | BSE: 544210
₹987.40 
-45.85 (-4.44 %)
Last Updated: 04 Apr 2025 03:59 PM
BULLISH
Overview
Open (₹) 1,037.50
High (₹) 1,047.95
Low (₹) 963.25
Prev. Close (₹) 1,033.25
Volume 1,07,018
VWAP (₹) 973.62
ROCE (%) 21.20
Industry P/E 44.73
TTM P/E 30.80
P/B Ratio 5.73
Market Cap (₹) Cr.18,709.59
Dividend Yield (%)0.30
EPS (₹) 27.54
ROE15.98%
Sales Growth (%) 11.23
Profit Growth (%)-6.10
Day Range
1,047.951,047.95
52 Week Range
911.751,577.50
Historical Returns
Returns (6M)
-25.83 %
Returns (1Y)
-27.35 %
Returns (3Y)
-27.35 %
Returns (5Y)
-27.35 %
Returns (6M)
-25.83 %
Returns (1Y)
-27.35 %
Returns (3Y)
-27.35 %
Returns (5Y)
-27.35 %
SWOT Analysis
Technicals
Technical Rating
BULLISHRSI 25.07
MFI 39.67
ATR 57.80
Commodity Channel Index -70.43
ROC125 -28.64
ROC21 -19.50
Williams %R -85.19
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,000.89 | 1,020.07 | 1,040.49 | 980.47 | 961.29 | 940.87 | 921.69 |
| Week Ago | 1,010.04 | 1,024.32 | 1,039.34 | 995.02 | 980.74 | 965.72 | 951.44 |
| Month Ago | 1,242.95 | 1,314.55 | 1,381.15 | 1,176.35 | 1,104.75 | 1,038.15 | 966.55 |
EMA & SMA
987.40
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
13
5 Day 988.13
9 Day 979.13
10 Day 986.76
12 Day 1022.30
14 Day 1039.85
20 Day 1103.92
26 Day 1131.84
50 Day 1261.80
100 Day 1327.12
200 Day N/A
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 04 Apr, 2025 | BSE India | Please find enclosed herewith a Press Release titled \Emcure''s European subsidiary Tillomed acquires strategic pharma portfolio from Manx.\ |
| 01 Apr, 2025 | BSE India | Please find enclosed herewith a Press Release titled \Emcutix and WiQo Signs Exclusive Licensing Partnership to revolutionize Derma-cosmetic Treatments in India\ by Emcutix Biopharmaceuticals Limited, a subsidiary of Emcure Pharmaceuticals Limited. |
| 01 Apr, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled ""Emcutix and WiQo Sign Exclusive Licensing Partnership to revolutionize Derma-cosmetic Treatments in India"". |
| 31 Mar, 2025 | BSE India | Please find enclosed herewith a Press Release titled \Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI\, by Gennova Biopharmaceuticals Limited, a subsidiary of Emcure Pharmaceuticals Limited. |
| 31 Mar, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 31, 2025, titled ""Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI"". |
| 25 Mar, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange about Closure of Trading Window |
| 25 Mar, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 24 Mar, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding Allotment of Securities |
| 24 Mar, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding allotment of 51500 securities pursuant to ESOP/ESPS at its meeting held on March 24, 2025 |
| 24 Mar, 2025 | BSE India | Intimation under Regulation 30 of SEBI Listing Regulations, 2015, for allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure- Employee Stock Option Scheme 2013 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 25 Jan, 2025 | 06 Feb, 2025 |
| Quarterly Results | -- | 29 Oct, 2024 | 07 Nov, 2024 |
| Quarterly Results | -- | 07 Aug, 2024 | 13 Aug, 2024 |
Share Holding Pattern
| Owner Name | Dec, 2024 | ||||
|---|---|---|---|---|---|
| Promoter Group | 77.94% | 0% | 0% | 0% | 0% |
| Foreign Institutions + | 3.05% | 0% | 0% | 0% | 0% |
| Domestic Institutions + | 3.87% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 15.14% | 0% | 0% | 0% | 0% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Emcure Pharmaceuticals
Emcure Pharmaceuticals is a Public Limited Listed company incorporated on 16/04/1981 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231PN1981PLC024251 and registration number is 024251. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3497.66 Cr. and Equity Capital is Rs. 181.15 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1981
Managing Director
Mr. Satish Ramanlal Mehta
NSE Symbol
EMCURE
Emcure Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Berjis Minoo Desai | Chairman & Non-Exe.Director |
| Mr. Satish Ramanlal Mehta | Managing Director & CEO |
| Mr. Sunil Rajanikant Mehta | Whole Time Director |
| Ms. Namita Vikas Thapar | Whole Time Director |
| Mr. Samit Satish Mehta | Whole Time Director |
| Mr. Mukund Keshao Gurjar | Whole Time Director |
| Mr. Samonnoi Banerjee | Non Exe. & Nominee Director |
| Mr. Palamadai Sundararajan Jayakumar | Independent Director |
| Mr. Vijay Keshav Gokhale | Independent Director |
| Ms. Vidya Rajiv Yeravdekar | Independent Director |
| Mr. Shailesh Kripalu Ayyangar | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35  ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
| Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50  ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Emcure Pharmaceuticals
What is the share price of Emcure Pharmaceuticals?
The share price of Emcure Pharmaceuticals on 04 Apr, 2025 is ₹ 987.40.
What is 52W high and 52W low share price of Emcure Pharmaceuticals?
The highest and lowest 52W share prices of Emcure Pharmaceuticals are ₹ 1577.500 and ₹ 911.750
What is the market cap of Emcure Pharmaceuticals?
The market capitalization of Emcure Pharmaceuticals as of 04 Apr, 2025 is ₹ 18,709.59 Crores
What is the P/E ratio of Emcure Pharmaceuticals?
The current P/E ratio of Emcure Pharmaceuticals as of 04 Apr, 2025 is 44.73
What is the PB ratio of Emcure Pharmaceuticals?
The PB ratio of Emcure Pharmaceuticals as of 04 Apr, 2025 is 5.73
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)